SAFE OPIoID. Get the answers from the leading experts in pain. Qualifies for up to Hours of CME Credit,

Transcription

1 the American Academy of Pain Medicine SAFE OPIoID PRescribing February 25 26, 2012 Palm Springs, CA REVERSING THE TREND: A NATIONAL HEALTH PRIORITY Get the answers from the leading experts in pain Qualifies for up to Hours of CME Credit, including up to 20 hours of Performance Improvement CME*

2 COURSE Head Highlights SAFE OPIoID PRescribing February 25 26, 2012 Palm Springs, CA A National Health Priority The tension between patients who are seeking pain relief and the prescription drug abuse epidemic raises concern for many primary care physicians (PCPs). In fact, the American Academy of Pain Medicine (AAPM) has identified that safe pain management is one of the top five concerns among PCPs. Add all the media attention and regulatory scrutiny that surround opioid prescribing, and many PCPs simply back away from treating pain. However, recent research cited in the 2011 Institute of Medicine s (IOM) report Relieving Pain in America shows that PCPs can play a very important part in helping people with pain. PCPs treat approximately 52% of chronic pain patients. 1 Of the chronic pain patients treated on an ongoing basis, 51% continue with PCPs. 1 Twenty-nine percent of PCPs prescribe opioids less often than they deem appropriate because of regulatory oversight concerns. 1 The PCP s response (to a pain patient s request for help) may be crucial in providing timely relief and preventing acute pain from progressing to a persistent or chronic state. 2 The IOM report strongly advocates for many of the axioms AAPM has long embraced, and as a result, AAPM is running this course concurrently with AAPM s 28th Annual Meeting, which is themed This Is Our Time. World-Class Pain CME from the Experts in Pain AAPM s Safe Opioid Prescribing course is a new educational offering for PCPs and midlevel prescribers from the experts in pain. This course not only will provide you with the opportunity to learn facts about better pain care, but will also scientifically dispel common myths and disclose unknown facts about safe opioid prescribing. A few examples of questions that will be addressed include the following: Is it true that the starting dose of methadone is responsible for many overdose deaths? Are benzodiazepines recommended when a patient is taking opioids? What is the role of opioids in sleep apnea? Are extended-release opioid formulations indicated for acute pain? Addressing quality pain care across all practice settings remains a moral and ethical obligation to society and Why Attend AAPM s Safe Opioid Prescribing Course? 1. World-renowned Experts AAPM has advocated for safe pain care for more than 28 years. The Safe Opioid Prescribing course is planned with input from a broad base of physician experts. They speak your speak. They can help you troubleshoot the cases you see each day in your practice. And, they can answer your questions. Face to face. In other words, the Safe Opioid Prescribing course is designed to be relevant to you and directly applicable to your practice. 2. Outstanding Education ACCME s Accreditation with Commendation There is another reason you should not miss this course: the outstanding quality of AAPM s education. AAPM s education was recently resurveyed by the Accreditation Council for Continuing Medical Education (ACCME) and was awarded Accreditation with Commendation for a term of 6 years as a provider of continuing medical education for physicians. The 6-year accreditation is the highest accreditation awarded by the ACCME, and very few providers have received it under the new accreditation criteria. Although AAPM education does have an established reputation, receiving ACCME Accreditation with Commendation is a first in our 28-year history. This is a must-attend educational event for PCPs because it offers outstanding education by leading scientists and clinician experts in pain. The recently released IOM report validates the need for AAPM to complete our mission, and the Safe Opioid Prescribing course provides the venue to take the necessary steps toward eliminating the major public health problem of pain. Will you do your part in Palm Springs, CA, February 25 26, 2012? Reserve your spot. Make your travel plans. Come Connect, Learn, and Make a Difference. REGISTER TODAY! to our patients. Lynn R. Webster, MD, Safe Opioid Prescribing Course Chair References 1. Breuer B, Cruciani, Portenoy RK. Pain management by the primary care physicians, pain physicians, chiropractors, and acupuncturists: A national survey. Southern Med J. 2010;103(8): Dobkin P, Boothroyd L. Organizing health services for patients with chronic pain: when there is a will there is a way. Pain Med.2008; 9(7): visit for more information.

3 Head Course Highlights A National Health Priority: The Public Health Crisis of Pain Program Goals AAPM has established four overarching goals for this program. These goals both reflect AAPM s long-term, public-healthoriented vision and provide the framework for the Safe Opioid Prescribing course. 1. Decrease the number of unintentional deaths from prescription opioid analgesics related to chronic pain treatment plans. 2. Decrease the number of emergency room admissions for prescription drug overdoses in patients prescribed opioid analgesics as part of chronic pain treatment plans. 3. Reduce the number of admissions to opioid substance abuse treatment centers for patients prescribed opioid analgesics as part of their chronic pain treatment plans. 4. No decrease in access to appropriate opioid therapy in the treatment of chronic pain. Intended Audience All PCPs and clinicians committed to minimizing the risks and reducing the number of deaths associated with opioid analgesics in the treatment of chronic pain maintaining access to the appropriate use of opioid analgesics for the millions of American adults who suffer from chronic pain. Educational Objectives After attending the Safe Opioid Prescribing course, learners will be better able to identify the known root causes related to the abuse, misuse, and unintentional deaths related to opioid analgesic use in the treatment of chronic pain understand the potential risks of abuse and diversion for both conventional and emerging opioid formulations incorporate the core components of the Federation of State Medical Boards (FSMB) Model Policy for the Use of Controlled Substances into their practices implement multifaceted interventions aimed at decreasing the risks for opioid analgesic abuse by chronic pain patients improve the implementation of best practices related to patient adherence, assessment, and evaluation, and prescriber and patient communication. Educational objectives for sessions and workshops are outlined on AAPM s website at Expected Outcomes As a result of the CME activity and after attending the Safe Opioid Prescribing course, prescribers will be able to use the knowledge of safe opioid prescribing practices to implement evidence-based clinical tools and protocols in their practice understand the prevalence of pill shopping, the significant risk it presents to prescribers, and how to use state prescription monitoring programs (PMPs) to mitigate that risk demonstrate improved knowledge of using urine drug tests for diagnosis and ongoing treatment, which includes the ability to implement uniform treatment protocols in the PCP setting, including uniform interpretation, understanding when to enact follow-up tests, using effective tools for communicating results with patients, and documenting results in the patient medical records demonstrate improved knowledge of extended-release and long-acting opioid pharmacology, including dosage forms, intervals, key instructions, drug interactions, adverse events, relative potency to oral morphine, and relative use in opioidtolerant patients. The competing public health crises of undertreated pain and prescription drug abuse continue to increase the need for safe and effective pain management strategies within the busy primary care practice. AAPM, as the premier physician organization committed to advancing the quality and practice of pain medicine, recognizes pain management and opioid therapy as a top 5 concern among PCPs. Limited professional education in effective pain management strategies leaves PCPs fearful of regulatory scrutiny and reluctant to implement chronic opioid therapy. Yet, pain medicine can be an effective and appropriate component of a comprehensive chronic-pain treatment plan. The missing component, however, is proper education for both providers and patients. AAPM s Safe Opioid Prescribing course has been created with this in mind and will help you to reduce system-based barriers to safe prescribing practices improve clinician-patient interactions reverse the trend and reduce deaths and adverse events related to extended-release and long-acting opioid therapy negotiate ethical complexities of chronic pain patients implement practical strategies to manage risks and preserve professional integrity reduce fear of regulatory scrutiny feel more comfortable using opioids when appropriate. Register at

4 Program sessions and workshops Program Structure AAPM s Safe Opioid Prescribing course addresses much more than the standard how to prescribe continuing medical education (CME). The course combines highly interactive sessions presented by international pain experts from a broad base of treatment settings with robust workshops, real case studies, and lively question-and-answer sessions. It includes everything you need to acquire the expertise and confidence to help your patients with pain and make a difference in this national health crisis. The Safe Opioid Prescribing course is a 2-day course aimed at PCPs who seek to provide better care for their patients with pain from the experts in pain. A total of 11 interactive, case-based learning sessions will provide information on the most relevant topics in pain by the foremost experts in pain. The question-and-answer segments that follow each session will help you apply each session topic to the patients you see every day in your practice. Day 1 The first day of the Safe Opioid Prescribing course will consist of nine expert-led general sessions. The sessions will be highly interactive with time set aside to answer your questions and discuss how they relate to your practice. Assessments and practice-change surveys will be administered before and after the course at regular intervals to help establish long-term knowledge and core competencies. Nine expert-led general sessions Understanding the Public Health Problem of Opioid-Related Harm and the Regulatory Response Conducting Comprehensive Risk Assessments and Evaluation Strategy for ER Opioid Therapy Unintentional Overdose Deaths: Reversing the Trend Preventing Suicide Through Proper Assessment Extended-Release Opioid Formulations: What All Prescribers Need to Know Opioid Therapy: Effective Monitoring and Maintenance Strategies Initiation, Rotation, and Discontinuation of Opioid Therapy Implementing and Managing Effective Risk Management Strategy Into Your Primary Care Practice Protecting Your Practice: Pain Medicine and the Law Day 2 The second day will begin with three additional expert-led general sessions. Participants will then break into smaller groups and spend the day rotating through two repeating workshops on prescription monitoring programs and urine drug tests. Three expert-led general sessions Diversion: What We Know and What We Don t Know Prescribing Opioids for Acute and Postoperative Pain Safe Use of ER Opioids: Counseling Patients and Caregivers Two repeating interactive workshop topics Urine Drug Tests: Why, Who, When, and How to Interpret Results Prescription Monitoring Programs as Standard Practice: Improving Access, Utilization, and Patient Care Continuing Medical Education Credits Accreditation Council for Continuing Medical Education AAPM is accredited by the ACCME to sponsor continuing medical education (CME) for physicians. AAPM designates this educational activity for up to AMA PRA Category 1 Credits.* Self-Assessment Modules 2 AMA PRA Category 1 Credits Live Activity AMA PRA Category 1 Credits Ongoing Performance Improvement (PI) CME Activity 20 AMA PRA Category 1 Credits will also be available for future optional participation. American Academy of Family Physicians (AAFP) This live activity, Safe Opioid Prescribing, from February 25 26, 2012, has been reviewed and is acceptable for up to prescribed credits by the American Academy of Family Physicians. Because some sessions run concurrently, no more than credits may be reported. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACCME s Accreditation with Commendation Awarded to AAPM s Education AAPM s education was recently resurveyed by the ACCME and awarded Accreditation with Commendation for a term of 6 years as a provider of CME for physicians. The 6-year accreditation is the highest accreditation awarded by the ACCME. The ACCME rigorously evaluates the overall CME programs of institutions according to standards adopted by all seven sponsoring organizations of the ACCME, including the American Board of Medical Specialties, the American Hospital Association, the American Medical Association, the Association for Hospital Medical Education, the Association of American Medical Colleges, the Council of Medical Specialty Societies, and the Federation of State Medical Boards of the U.S. ACCME accreditation seeks to assure both physicians and the public that CME activities provided by AAPM meet the high standards of the essential areas, elements, policies, criteria, and standards for accreditation as specified by the ACCME. commercial support The AAPM Safe Opioid Prescribing Course is supported by educational grants from Ameritox Ltd., Endo Pharmaceuticals Inc., Mallinckrodt LLC, a Covidien company, Millennium Laboratories, Pfizer Inc., and Purdue Pharma LP. Four-star Diamond Diamond Platinum SM GOLD visit for more information.

5 Program Committee Lynn R. Webster, MD Safe Opioid Prescribing Course Chair Medical Director Lifetree Clinical Research Salt Lake City, UT Jeremy A. Adler, MS PA-C Pacific Pain Medicine Consultants Encinitas, CA Robin J. Hamill-Ruth, MD Director of Clinical Pain Research University of Virginia Health Sciences Center Charlottesville, VA Debra Hobbins, APRN LSAC Executive Research Scientist Lifetree Center for Neuroscience Research Salt Lake City, UT Nancy A. Poffenberger, PA-C CIV USA MEDCOM MAMC OTSG Pain Task Force Interdisciplinary Pain Management Center Clinical Pharmacist/PA-C Pain Consultant Madigan Army Medical Center Dupont, WA Joseph J. Ruane, DO Medical Director McConnell Heart Health Center Columbus, OH Matthew J. Bair, MD Assistant Professor of Medicine Indiana University School of Medicine Roundebush VA Medical Center Indianapolis, IN Derek Hoffman Director of Operations Lifetree Clinical Research Salt Lake City, UT Barbara St. Marie, ANP GNP RN-BC Supervisor of Pain and Palliative Care Fairview Ridges Hospital Burnsville, MN Michel Y. Dubois, MD NYU Center for the Treatment and Study of Pain New York, NY Sean Mackey, MD PhD Director, Pain Management Division Stanford University Medical Center Palo Alto, CA Michael Schiesser, MD Chief Medical Officer Pain Management Options Bellevue, WA Scott M. Fishman, MD Chief, Pain Medicine Lawrence J. Ellison Ambulatory Care Center University of California Davis School of Medicine Sacramento, CA Vitaly Gordin, MD Director, Pain Division Penn State University College of Medicine Hershey, PA Bill McCarberg, MD Chronic Pain Management Program Kaiser Permanente Escondido, CA Steven D. Passik, PhD Professor of Psychiatry and Anesthesiology Vanderbilt University School of Medicine Nashville, TN Dana L. Simon, MD Medical Center Anesthesiologists PC West Des Moines, IA Robert E. Wailes, MD Medical Director Pacific Pain Medicine Consultants Encinitas, CA J. David Haddox, DDS MD Vice President, Health Policy Purdue Pharma LP Stamford, CT Phil Saigh Executive Director AAPM Staff Mary O Keefe Education Coordinator Susie Flynn Director of Education Elizabeth Tatum Education Coordinator Register at

6 General Information beyond the 2-day course Several other components of the Safe Opioid Prescribing course are being created to expand its impact. Advocacy and Public Education Initiative To complement the prescriber education program, the Academy plans to collaborate with key stakeholders to organize a medication take-back event in Palm Springs, CA, adjacent to the Safe Opioid Prescribing course. This demonstrates a best practice related to reducing diversion of opioids and affords an opportunity to connect with local antidrug coalitions, parents, teachers, and law enforcement officials about the harms of prescription drug abuse and diversion and the value of take-back/safe-disposal programs. Integration of Maintenance of Licensing (MOL) This CME intervention has the potential to be a vital component of the MOL process through ongoing self-assessment and demonstration of safe opioid prescribing competence. Quality Improvement and Patient Safety Initiatives The Academy anticipates that this initiative will provide multiple opportunities to address and overcome the inherent barriers to safe opioid prescribing practices in the primary care setting. Best practices and lessons learned from this longitudinal CME activity can also be integrated into regional and national patient safety and quality improvement initiatives. ONLINE TOOL KIT An online Web page of tools and resources will be made available for attendees to help support providers and help them educate other clinicians in their practice as well as patients, families, and the community in which they live and practice. SPECIAL 1-DAY ADMISSION TO AAPM s ANNUAL MEETING AAPM s 28th Annual Meeting will be running concurrent to the Safe Opioid Prescribing course. A special 1-day admission plus Safe Opioid Prescribing course fee has been created to allow you to attend the Annual Meeting on Friday, February 24, before the Safe Opioid Prescribing course begins. Visit to see the complete schedule. Networking Opportunity Friday, February 24, 5:45 7:15 pm You are invited to attend the 28th Annual Meeting Welcome Reception on Friday, February 24, in the Exhibit Hall. Network with colleagues, view scientific posters, and learn about new pain products and services. Hotel Information Renaissance Palm Springs Hotel 888 Tahquitz Canyon Way Palm Springs, CA The Renaissance Palm Springs Hotel is AAPM s 28th Annual Meeting headquarters hotel. AAPM s group rate is $175 single/double plus all applicable taxes. To obtain the group rate, identify yourself as attending the AAPM s 28th Annual Meeting. Please note this rate is offered until January 23, 2012, provided that rooms in the AAPM block are still available. Reservations made after the above date will be taken on a space- and rate-available basis. Disclosures It is the policy of the AAPM to plan and implement educational activities in accordance with the ACCME Essential Areas and Elements, incorporating updated accreditation criteria and revised commercial support standards to ensure balance, independence, objectivity, and scientific rigor. All program faculty and planners are required to disclose all financial relationships they may have or have had within the last 12 months with commercial interests whose products or services are related to the subject matter of the presentation. Disclosure information will be made available to attendees at the meeting and on AAPM s website at Faculty members will also be expected to disclose this information to the audience both verbally and on printed introductory slides at the beginning of their presentations. Faculty members are required to inform program participants when they will be discussing any unlabeled uses of products regulated by the U.S. Food and Drug Administration. For the complete list of disclosures for the program committee and faculty, please see Jeremy A. Adler, MS PA-C Azur Pharmaceuticals (honorarium speaker); Endo Pharmaceuticals (honorarium speaker); Johnson & Johnson (honorarium speaker); Pfizer/King (honorarium speaker); St. Jude Medical (honorarium speaker); Victory Pharma (honorarium speaker) Matthew J. Bair, MD Michel Y. Dubois, MD Scott M. Fishman, MD Vitaly Gordin, MD J. David Haddox, DDS MD Purdue Pharma L.P. (salary and benefits employment) Robin J. Hamill-Ruth, MD Piezo Resonance (consulting fee consultant); Recro Pharma (consulting fee consultant) Debra Hobbins, APRN LSAC Derek Hoffman Sean Mackey, MD PhD Bill McCarberg, MD Endo (honorarium speaker); Forest (honorarium speaker); NeurogesX (honorarium speaker); Pricara (honorarium speaker) Steven D. Passik, PhD Ameritox (honorarium consultant); Cephalon (honorarium speaker/consultant); Covidien (research funding speaker/consultant); Endo (honorarium consultant); Janssen (honorarium speaker/consultant); Millenium (honorarium speaker/consultant); Pfizer (honorarium consultant); Pharmacofore (honorarium consultant); Purdue Pharma (honorarium consultant); Quest (honorarium speaker/consultant) Nancy A. Poffenberger, PA-C CIV USA MEDCOM MAMC Joseph J. Ruane, DO Genzyme Biosurgery (honorarium consultant/ speaker); Novartis (honorarium consultant); Pfizer, Inc. (honorarium consultant/speaker) Barbara St. Marie, ANP GNP RN-BC Michael Schiesser, MD American Pain Foundation (grant Washington Pain Alliance Development); Capital Toxicology (honoraria speaker); Creekside Sleep Medicine Center LLC (shares owner); Logistic Innovations (honoraria speaker); Pain Management Options LLC (salary chief medical officer); Physician s Insurance A Mutual Company (consulting fee risk management/cme development); Purdue Pharma LP (grant Washington Pain Portal); Purdue Pharma LP (BuTrans) (honoraria speaker/consultant); Reckitt-Benkeiser (Suboxone) (honoraria speaker); Regence Blue Shield (fee consulting); Swedish Medical Center (honoraria speaker); The Peer Group (honoraria speaker); Washington Academy of Pain Management (honoraria speaker) Dana L. Simon, MD Robert E. Wailes, MD Vertiflex (consulting fees consulting) Lynn R. Webster, MD Adolor Corp. (research); Alkermes, Inc (research); Allergan, Inc (research); AlphaBioCom (honoraria consultant/advisory board); Astellas (research); AstraZeneca (honoraria consultant/advisory board/research); Bayer Healthcare (research); BioDelivery Systems International (research); Boston Scientific (honoraria consultant/advisory board/research); Cephalon (honoraria consultant/advisory board/research); Collegium Pharmaceuticals (research); Covidien (research); Covidien Mallinckrodt (honoraria consultant/advisory board); Eisai (research); Elan Pharmaceuticals (research); Gilead Sciences (research); GlaxoSmithKline (research); Identigene (Sorenson) (research); King Pharmaceuticals (research); Meagan Medical (research); Medtronic (research); Merck (research); Naurex (research); Nektar Therapeutics (research); NeurogesX, Inc (research); Nevro Corporation (consultant/ honoraria/advisory board); Novartis (research); Pfizer (research); SchaBar (research); Shionogi USA, Inc (research); St. Renatus (research); SuCampo Pharma Americas, USA (research); Takeda (research); TEVA Pharmaceuticals (Sub-I) (research); Theravance, Inc (honoraria consultant/advisory board/research); Vanda (research); Vertex (research); Xanodyne Pharmaceuticals (research) AAPM STAFF Phil Saigh Susie Flynn BioSante (stock); Celgene (stock) Mary O Keefe Elizabeth Tatum visit for more information.

7 AAPM Safe Opioid Prescribing February 25 26, 2012 Palm Springs, CA A stand-alone prescriber education program that runs concurrent to the AAPM 28th Annual Meeting For Office Use Only Date Received: Cust. # Ord.# 1- Full name First name for badge Credentials Facility Facility City/State Preferred address ( home office) City/State/ZIP Preferred contact phone number (required) (required) Emergency contact name Day phone Evening phone Fees Physician Safe Opioid Prescribing Course Only $389 Physician Safe Opioid Prescribing Course + 1-Day Access (Friday, Feb. 24) to AAPM Annual Meeting $599 Affiliate & Resident Safe Opioid Prescribing Course Only $289 Affiliate & Resident Safe Opioid Prescribing Course + 1-Day Access (Friday, Feb. 24) to AAPM Annual Meeting $ Currently, I am authorized to access my state Prescription Monitoring Program (PMP) (Q1). YES NO 2. Currently, I utilize the Prescription Monitoring Program (PMP) as a clinical decision tool (Q2). YES NO 2a. If YES to Question 2: How frequently do you consult your PMP in relation to the number of controlled substance prescriptions you write? (Please select one of the options below.) (Q2A) Prior to every prescription Once in 5 prescriptions Once in 10 prescriptions Once in 20 prescriptions Once in 100 prescriptions Once in 500 prescriptions Never 3. Check here if you are interested in earning additional CME Credits (20 hours) by engaging in a performance improvement (PI) activity in your practice setting. (Q3) (Note: This CME activity is intended to support clinicians as they implement safe opioid prescribing practices on the ground and to measure patient outcomes.) 4. Check here if you are interested in receiving information about a comprehensive examination leading to a Certificate of Knowledge in the safe use of opioid analgesics in the treatment of pain. (Q4) 4 Ways to Register Online: Phone: * Fax: * Mail application to: Safe Opioid Prescribing Registration, PO Box 839, Glenview, IL TOTAL: $ *Credit card payment only Payment (Credit card Payment Only) MasterCard VISA American Express Discover Account number Expiration Date Cardholder s name (please print) signature If rebilling of a credit card charge is necessary, a $75 processing fee will be charged. I authorize AAPM to charge the above listed credit card amounts reasonably deemed by AAPM to be accurate and appropriate. Cancellation Policy: All cancellations must be submitted in writing. A $100 processing fee applies to all cancellations. No refunds will be made on cancellations postmarked after February 22, All refunds will be processed after the course.

8 4700 W. Lake Avenue Glenview, IL the American Academy of Pain Medicine SAFE OPIoID PRescribing February 25 26, 2012 Palm Springs, CA REVERSING THE TREND: A NATIONAL HEALTH PRIORITY Get the answers from the leading experts in pain Qualifies for up to Hours of CME Credit including up to 20 hours of Performance Improvement CME*